← Back to Clinical Trials
Recruiting NCT07161908

NCT07161908 Controlled Remote Monitoring and Optimization of Oxygen Therapy in Preterm Infants

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07161908
Status Recruiting
Phase
Sponsor Institute of Health Information and Statistics of the Czech Republic
Condition BPD - Bronchopulmonary Dysplasia
Study Type INTERVENTIONAL
Enrollment 70 participants
Start Date 2025-08-25
Primary Completion 2026-11

Trial Parameters

Condition BPD - Bronchopulmonary Dysplasia
Sponsor Institute of Health Information and Statistics of the Czech Republic
Study Type INTERVENTIONAL
Phase N/A
Enrollment 70
Sex ALL
Min Age N/A
Max Age 36 Weeks
Start Date 2025-08-25
Completion 2026-11
Interventions
Pulse oximeter

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

The project is a national, prospective, multicenter, interventional pilot project focused on controlled remote monitoring and optimization of oxygen therapy for premature infants in the Czech Republic. The primary aim of the project is to prepare, test, and develop a proposal for a national methodology for the care of preterm newborns. This will reduce health risks in premature infants and minimize the negative impacts on the overall development of the child and the family of the premature infant.

Eligibility Criteria

Inclusion Criteria: * infants born before 31+6 weeks gestation * signed consent for participation in the project and consent for the processing of personal data * diagnosed with bronchopulmonary dysplasia * type of pulmonary ventilation - low-flow nasal cannulas Exclusion Criteria: * unsigned consent for participation in the project and/or consent for the processing of personal data * child diagnosed with conditions other than bronchopulmonary dysplasia (BPD) at high risk of long-term hypoxia - selected chronic cardiovascular, neurological, and muscular diseases, e.g., significant congenital heart defects, congenital central nervous system developmental disorders, genetic diseases associated with the risk of hypoventilation, central apneas, severe early obstructive sleep apnea * other chronic respiratory diseases besides BPD - e.g., cystic fibrosis, chronic aspiration * insufficient therapy through long-term home oxygen therapy * tracheostomy

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology